Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Rydapt 25mg Soft Capsules - SFDA Drug Approval Details

Approvals/SFDA/Rydapt 25mg Soft Capsules

Authorized

NCE

Rydapt 25mg Soft Capsules

Unknown🇸🇦 Saudi Food and Drug Authority

Approval Date: N/A
Approval ID: 32adea178cb37ea5
Company: Unknown
Type: NCE

Approval Details

Approval Id: 32adea178cb37ea5
Drug Approval Sfda Name: Rydapt 25mg Soft Capsules
Trade Name: Rydapt 25mg Soft Capsules
Generic Name: Midostaurin
Register Number: 2408222548
Register Year: 2022
Drug Type: NCE
Route Of Administration: Oral use
Package Type: Blister
Package Size: 112
Legal Status: Prescription
Authorization Status: Valid
Marketing Status: Marketed
Product Control: Uncontrolled
Storage Conditions: do not store above 30°c
Shelf Life: 36 Months
Distribution Site: Hospital
Description Code: 7000002308-25-100000073660
Price: 58587.25

Active Ingredients

Authorized

Quick Info

Agency

SFDA

Country

🇸🇦

Approval ID

32adea178cb37ea5

Type

NCE

Back to SFDA Approvals